VYDRA, Jan, C SALEK, J SCHWARZ, Petr CETKOVSKÝ, Pavel ŽÁK, Jan NOVÁK, Veronika PETEČUKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. In Haematologica. 2017. ISSN 0390-6078. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1402099, author = {Vydra, Jan and SALEK, C and SCHWARZ, J and Cetkovský, Petr and Žák, Pavel and Novák, Jan and Petečuková, Veronika and Mayer, Jiří and Ráčil, Zdeněk}, booktitle = {Haematologica}, language = {eng}, title = {Postremission therapy for AML with intermediate risk cytogenetics in first complete remission.}, year = {2017} }
TY - CONF ID - 1402099 AU - Vydra, Jan - SALEK, C - SCHWARZ, J - Cetkovský, Petr - Žák, Pavel - Novák, Jan - Petečuková, Veronika - Mayer, Jiří - Ráčil, Zdeněk PY - 2017 TI - Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. ER -
VYDRA, Jan, C SALEK, J SCHWARZ, Petr CETKOVSKÝ, Pavel ŽÁK, Jan NOVÁK, Veronika PETEČUKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. In \textit{Haematologica}. 2017. ISSN~0390-6078.
|